COMMUNIQUÉS West-GlobeNewswire

TG Therapeutics Announces Completion of Target Enrollment in the ULTIMATE Phase 3 Trials in Multiple Sclerosis
07/08/2018
NEW YORK, Aug. 07, 2018 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced that target enrollment in the ULTIMATE I and II Phase 3 trials has been achieved. ULTIMATE I and II are two independent [...]
Ziopharm Oncology Announces Changes to its Board of Directors
07/08/2018
Scott Tarriff, CEO of Eagle Pharmaceuticals, Elected Lead Director Sir Murray Brennan, M.D., former U.S. Sen. Wyche Fowler to Step Down Paratek Pharmaceuticals CFO Doug Pag á n and Scholar Rock COO Elan Ezickson [...]
Avadel Pharmaceuticals Reports Second Quarter 2018 Financial Results
07/08/2018
DUBLIN, Ireland, Aug. 07, 2018 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (NASDAQ: AVDL), a company focused on providing innovative medicines for chronic urological, central nervous system, and sleep disorders, [...]
Spark Therapeutics Reports Second Quarter 2018 Financial Results and Recent Business Progress
07/08/2018
As of July 13, 2018, preliminary Phase 1/2 data for investigational SPK-8011 for hemophilia A show: A 97-percent reduction in annualized bleeding rate (ABR) and 97-percent reduction in annualized infusion rate (AIR) [...]
BioCorRx Provides Update on BICX102
07/08/2018
ANAHEIM, CA, Aug. 07, 2018 (GLOBE NEWSWIRE) -- BioCorRx Inc. (OTCQB: BICX) (the “Company”) , a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions, today announced a general [...]
Avalon GloboCare Forms Strategic Partnership with Weill Cornell Medical College to Co-develop Technologies and Bio-production of CAR-T Therapy
07/08/2018
FREEHOLD, N.J., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (OTCQB: AVCO), a leading global developer of cell-based technologies and therapeutics, announced today that the Company has formed a strategic [...]
Melinta Therapeutics Reports Second Quarter 2018 Financial Results
07/08/2018
Solid Performance from New Product Launches Vabomere TM Granted NTAP Status by CMS Strengthened Financial Position Supports Continued Growth Completed Expansion and Cross-Training of Experienced Anti-infective Sales [...]
Elite Pharmaceuticals Appoints Aqeel A. Fatmi, Ph.D. to Its Board of Directors
07/08/2018
NORTHVALE, N.J., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB: ELTP) announced today the appointment of Aqeel A. Fatmi, Ph.D. to its Board of Directors. Dr. Fatmi [...]
Anavex Life Sciences to Announce Fiscal Third Quarter 2018 Financial Results on Thursday, August 9, 2018
07/08/2018
Conference Call and Webcast To be Held Thursday, August 9, 2018 at 4:30pm Eastern time NEW YORK, Aug. 07, 2018 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp., (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage [...]
Resverlogix Announces Seventh Positive Recommendation From The Data Safety Monitoring Board For Phase 3 Study of Apabetalone
07/08/2018
A data review by the independent Data Safety Monitoring Board resulted in a recommendation for the BETonMACE trial to continue as planned without any modification CALGARY, Alberta,, Aug. 07, 2018 (GLOBE NEWSWIRE) -- [...]
Merus to Present at the 2018 Wedbush PacGrow Healthcare Conference
07/08/2018
UTRECHT, The Netherlands, Aug. 07, 2018 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq:MRUS), a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics (Biclonics®), today announced that [...]
Antares Pharma Reports Second Quarter 2018 Operating and Financial Results
07/08/2018
Increased Product Revenue, Positive Shift In Revenue Mix Highlights Second Quarter Results EWING, N.J., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (the Company) today reported operating and [...]
Recro Pharma Reports Second Quarter 2018 Financial Results
07/08/2018
Company to Host Conference Call Today at 8:00 AM ET MALVERN, Pa., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (NASDAQ:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for the [...]
Kamada Reports Financial Results for Second Quarter and First Six Months of 2018
07/08/2018
Total Revenues for Second Quarter were $33.8 Million, a 4% Increase Over Second Quarter of 2017 Total Revenues for First Half of 2018 were $51.3 Million, a 16% Increase Over First Half of 2017 Gross Profit for First [...]
Amicus Therapeutics Announces Second Quarter 2018 Financial Results and Corporate Updates
07/08/2018
2Q18 Net Product Sales of $21.3M Driven by Galafold ® (Migalastat) Expansion Company Increases FY18 Global Galafold Revenue Guidance to $80M-$90M Pompe Clinical, Regulatory and Manufacturing Activities Continue to [...]
MediWound Reports Second Quarter 2018 Financial Results
07/08/2018
Completion of enrollment of Phase 3 DETECT Study of NexoBrid ® Strategic discussions advancing with multiple parties Conference call begins today at 8:30 a.m. Eastern Time YAVNE, Israel, Aug. 07, 2018 (GLOBE NEWSWIRE [...]
Desert Medical Imaging Chooses CLS Mobile Laser & Non-Cooled Fiber for Clinical Trial of MRI-Guided Focal Laser Therapy for Prostate Cancer
07/08/2018
FRAMINGHAM, Mass., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems Americas, Inc . (CLS Americas), a subsidiary of CLS AB in Lund, Sweden, today announced its TRANBERG® Thermal Therapy System will be [...]
Cara Therapeutics Doses First Patient in Second Pivotal Phase 3 Efficacy Trial of KORSUVA™ (CR845/difelikefalin) Injection in Hemodialysis Patients with Chronic Kidney Disease-Associated Pruritus
07/08/2018
KALM™-2 trial to evaluate the efficacy of KORSUVA™ injection at 12 weeks STAMFORD, Conn., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and [...]
Madrigal Pharmaceuticals Reports 2018 Second Quarter Financial Results and Reviews Key Clinical Achievements
07/08/2018
Madrigal’s MGL-3196 NASH abstract selected for oral presentation in the presidential plenary clinical session of The Liver Meeting® 2018 during the American Association for the Study of Liver Diseases 2018 Annual [...]

Pages